Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Pharmaca Health Intelligence Oy
OY
Active
Y-tunnus 9003268-9
Korkeavuorenkatu 35, 00130
Helsinki
Other information service activities
·
NACE 6392
Est. 1978 · 48 years old
61 employees
Share
Finland
/
Companies
/
Other information service activities
/
Pharmaca Health Intelligence Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
11M
8M
6M
3M
0M
2021: 7M
7M
2021
2022: 7M (0% vs 2021)
7M
0%
2022
2023: 7M (0% vs 2022)
7M
0%
2023
2024: 8M (+14% vs 2023)
8M
+14%
2024
2025: 9M (+13% vs 2024)
9M
+13%
2025
EBITDA
EUR millions
1M
1M
1M
0M
0M
2021: 1M
1M
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 1M (0% vs 2022)
1M
0%
2023
2024: 1M (0% vs 2023)
1M
0%
2024
2025: 1M (0% vs 2024)
1M
0%
2025
Income statement
EUR thousands
Item
2025
2024
2023
2022
2021
Revenue
9 065
8 003
7 307
7 258
6 676
Staff expenses
−5 182
−1 600
−3 763
−3 646
−3 142
EBITDA
1 212
1 089
1 131
948
1 132
Depreciation & amort.
−220
−89
−11
−5
−7
EBIT
992
1 000
1 121
943
1 125
Net financials
266
307
155
−64
391
Profit before tax
1 259
1 307
1 275
879
1 516
Tax
192
209
197
205
303
Net profit
1 066
1 098
1 078
674
1 213
Balance sheet
EUR thousands
Item
2025
2024
2023
2022
2021
Total assets
6 258
8 300
518 924
5 037
5 099
Equity
4 047
3 980
388 246
3 762
3 965
Long-term debt
0
0
0
54
42
Short-term debt
2 212
4 319
130 678
1 221
1 092
Total debt
2 212
4 319
130 678
1 275
1 135
Financial ratios
5-year trend
EBITDA margin
13,4 %
This company
15,8 %
Market median
This company
Market median
15% below market
2021
2025
Equity ratio
64,7 %
This company
38,2 %
Market median
This company
Market median
69% above market
2021
2025
Return on equity
26,4 %
This company
18,4 %
Market median
This company
Market median
43% above market
2021
2025
Net profit margin
11,8 %
This company
8,1 %
Market median
This company
Market median
46% above market
2021
2025
Asset turnover
1,45×
This company
1,12×
Market median
This company
Market median
29% above market
2021
2025
Debt / equity
0,55×
This company
0,62×
Market median
This company
Market median
11% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on Pharmaca Health Intelligence Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
